• Menu
  • About Melanoma
    • Melanoma 101
    • Melanoma & Skin of Color
    • Types of Melanoma
    • Melanoma Staging
    • Prevention
    • Early Detection
    • Stories
  • For Patients
    • Screening & Diagnosis
    • Just Diagnosed
    • Treatment Options
    • Clinical Trials
    • Patient Resources
  • Research
    • Research Overview
    • Request for Proposals
    • MRA Grant Awards
    • MRA Grant Mechanisms
    • Scientific Retreat
    • Research Resources
  • News
    • Blog
    • Sign Up for Emails
    • Annual Progress Reports
    • For Press
  • Get Involved
    • Donate
    • Events
    • Fundraise for MRA
    • Honor a Loved One
    • Sponsor a Named Award
    • Corporate Partnerships
    • Workplace Giving
    • Planned Giving
  • About MRA
    • Mission
    • Board of Directors
    • MRA Team
    • Scientific Advisory Panel
    • Grant Review Committee
    • Medical Advisory Panel
    • Dermatology Council
    • Financials
    • Careers
    • Corporate Allies

DONATE
  • Leading the Charge: Melanoma Research for the Next Decade

    MRA is laser-focused on advancing cutting-edge research needed to achieve our mission of curing melanoma. In fact, MRA has helped bring 15 new therapies to the clinic. But we are not resting on our laurels, because for as much progress as we’ve made, too many lives are still being tragically cut short.

    Our latest report features some of our key achievements over the past year, highlighting the many ways we continue to push the field forward.

    Read More
  • Applications Now Being Accepted: MRA Dermatology Fellowship Program

    We are pleased to announce applications are now be accepted for our Dermatology Fellowship Award program. MRA Dermatology Fellowships drive greater interest and focus on melanoma in dermatologic clinical practice and research related to the prevention, detection, diagnosis, and staging of melanoma, by investing in post-docs and medical residents focused on dermatology.

    Learn More
  • Melanoma at 33: A Testament to the Importance of Early Detection

    Before he landed his current office job in the energy sector, Matthew Ruiz worked outdoors for many years. He, along with many of his colleagues in the field, took very few precautions to protect themselves from harmful UV rays. As is the unfortunate reality for many people with a history of significant sun exposure, this lifestyle came full circle for Matthew in 2018 when he was diagnosed with melanoma.

    Read More
  • Improving AI for People of Color: Diagnosing Melanoma & Other Skin Cancers

    The problem with the existing AI algorithms is that they have been developed using images of moles from light skinned (white) individuals. As a result, they often are not sensitive enough in people with darker skin. Dr. Albert Chiou, young investigator on the L’Oréal Dermatological Beauty Brands-MRA Team Science Award, and his colleagues are working to improve AI, so it can help all people, regardless of skin tone.

    Read More
  • Melanoma Clinical Trial Success Story: From Patient Volunteer to No Evidence of Disease

    This Mom of three enrolled in a neoadjuvant clinical trial for Stage 3 melanoma. After two infusions of Opdualag, Shannon underwent a successful surgery where doctors removed all affected lymph nodes and tested them, revealing No Evidence of Disease (NED).

    Read More
  • Find a Clinical Trial

    Melanoma Clinical Trial Finder
  • Get Connected

    Find Support for melanoma
  • Latest Report

    Retreat Report Box 2023
  • Get Involved

    Get Involved with Melanoma Outreach
  • About MRA

    Melanoma video

What's New

02/02/2023 – MRA Dermatology Fellowship Program: Now Accepting Applications

02/01/2023 – Leading the Charge: Melanoma Research for the Next Decade - 2021-2022 Annual Report

01/23/2023 – Melanoma at 33: A Testament to the Importance of Early Detection

01/19/2023 – Nearly 100,000 Americans Estimated to be Diagnosed with Melanoma in 2023

01/11/2023 – Pioneering New Treatment Strategies for Melanoma

Login

I've lost my password

×
Melanoma Research Alliance

730 15th Street, NW
Washington, DC 20005
(202) 336-8935

info@curemelanoma.org

About Melanoma Research Alliance

As the largest non-profit funder of melanoma research, MRA has dedicated $143 million to date in support of the fight against melanoma.

CFC #14131

Privacy Statement